Compare PLOW & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLOW | RGNX |
|---|---|---|
| Founded | 1948 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 904.8M | 761.9M |
| IPO Year | 2010 | 2015 |
| Metric | PLOW | RGNX |
|---|---|---|
| Price | $40.23 | $10.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $39.00 | $30.38 |
| AVG Volume (30 Days) | 207.3K | ★ 1.1M |
| Earning Date | 02-23-2026 | 03-12-2026 |
| Dividend Yield | ★ 2.99% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $615,064,000.00 | $161,318,000.00 |
| Revenue This Year | $15.07 | $128.55 |
| Revenue Next Year | $10.40 | $47.33 |
| P/E Ratio | $22.56 | ★ N/A |
| Revenue Growth | 9.99 | ★ 91.30 |
| 52 Week Low | $21.30 | $5.04 |
| 52 Week High | $40.00 | $16.19 |
| Indicator | PLOW | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 74.34 | 36.91 |
| Support Level | $38.82 | $10.15 |
| Resistance Level | $40.00 | $11.20 |
| Average True Range (ATR) | 0.87 | 1.03 |
| MACD | 0.11 | -0.37 |
| Stochastic Oscillator | 88.43 | 18.58 |
Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.